Episode
Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil
- Podcast
- Business Of Biotech
- Published
- Aug 24, 2026
- Duration seconds
- 3365
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/biotech-investing-at-the-earliest-stages-with-sant-ventures-omar-khalil/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-of-biotech-123501/biotech-investing-at-the-earliest-stages-with-sant-ventures-omar-khalil.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding startups and early-stage biotech companies with a focus on clinical data and differentiation as the key value drivers. Omar talks about his interest in 'undruggable targets,' what's happening with the IPO market, an investor shift from biology risk to commercial risk, and building companies through a ve...